Oculus Innovative Sciences Inc. (NASDAQ:OCLS) shares fell 12% on Friday . The stock traded as low as $4.10 and last traded at $4.17, with a volume of 81,281 shares traded. The stock had previously closed at $4.74.

Separately, Maxim Group restated a “buy” rating and set a $3.00 price target on shares of Oculus Innovative Sciences in a report on Friday, June 17th.

The company has a 50 day moving average of $4.44 and a 200-day moving average of $4.86. The company’s market capitalization is $18.01 million.

Oculus Innovative Sciences (NASDAQ:OCLS) last issued its quarterly earnings results on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter. On average, equities analysts anticipate that Oculus Innovative Sciences Inc. will post ($0.37) EPS for the current year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.